Daily Cosmetic Research Analysis
Analyzed 9 papers and selected 3 impactful papers.
Summary
Three studies advance cosmetic and dermatologic science: a stem cell-derived hair organoid model enables efficacy testing for androgenic alopecia, a methacrylated hyaluronic acid–stabilized emulsion enhances dermal delivery and anti-photoaging activity of nicomenthyl, and a multi-technique analysis links animal fat triacylglycerol composition and shear to polymorphism relevant to product texture and stability.
Research Themes
- Organoid-based efficacy models for hair loss
- Polymer-stabilized emulsions for trans-stratum-corneum delivery
- Lipid polymorphism and processing effects in fat-based formulations
Selected Articles
1. Exploring the efficacy evaluation model for androgenic alopecia using hair organoids: Transcending conventional hair research.
An ES cell-derived, hair-bearing organoid model was established, in which 1 µM DHT reduced pigmented hair numbers and hair growth markers. Co-treatment with 200 µg/mL SOYACT or minoxidil restored hair counts and biomarker expression, validating the platform for assessing therapeutic and cosmetic anti-hair loss agents.
Impact: Introduces a human-relevant organoid system that recapitulates androgen-driven follicular changes and responds to both a drug and a certified cosmetic ingredient, bridging basic biology and product screening.
Clinical Implications: While preclinical, this platform can prioritize candidate therapies and cosmetic actives for androgenic alopecia, potentially accelerating translation and reducing reliance on less predictive in vitro assays.
Key Findings
- DHT at 1 µM significantly decreased pigmented hair numbers and hair growth biomarkers (e.g., SOX2, PCNA) in hair-bearing organoids.
- Co-treatment with 200 µg/mL SOYACT or minoxidil restored hair follicle numbers and biomarker expression.
- Efficacy of SOYACT was validated using MTT assays, RT-PCR, immunohistochemistry, and ex vivo organ culture.
- Organoids required approximately 100 days of ES cell culture to achieve hair follicle formation before testing.
Methodological Strengths
- Human-relevant ES cell–derived organoids with hair formation
- Multimodal efficacy readouts (MTT, RT-PCR, IHC, ex vivo organ culture)
Limitations
- Embryonic stem cell origin may not fully recapitulate adult scalp follicle biology.
- Short-term responses; durability and long-term cycling were not assessed.
Future Directions: Validate with patient-derived iPSCs and androgen-sensitive follicles, integrate vascular/immune components, and expand screening to diverse therapeutic and cosmetic libraries with benchmark comparisons to scalp explants.
BACKGROUND: The development of effective evaluation tools for anti-hair loss therapies is critical due to limitations in existing experimental systems. Hairy 3D skin models and hairy skin explants are not yet commercially viable, necessitating alternative approaches for assessing androgenic alopecia (AGA). OBJECTIVE: This study aimed to develop a hair-bearing organoid model derived from embryonic stem (ES) cells to evaluate the efficacy of compounds against AGA. METHODS: Organoids were cultured from ES cells for approximately 100 days until hair follicle formation began. AGA conditions were induced by treating organoids with dihydrotestosterone (DHT). The recovery effects were assessed using minoxidil (MXD) and soybean embryo extract (SOYACT), a cosmetic ingredient certified for mitigating hair loss. The efficacy of SOYACT was validated through MTT assays, RT-PCR, and ex vivo organ culture. Hair numbers were quantified, and biomarkers related to hair growth, including SOX2, PCNA were analyzed via immunohistochemistry. RESULTS: DHT treatment at 1 µM significantly reduced pigmented hair numbers and decreased expression of hair growth-associated biomarkers. Conversely, co-treatment with 200 μg/mL SOYACT or MXD mitigated these effects, restoring hair follicle numbers and biomarker expression levels. These findings demonstrated the successful induction of AGA conditions in hair-bearing organoids and their response to anti-hair loss ingredients. CONCLUSION: This study highlights the utility of hair-bearing organoids as a novel experimental model for evaluating AGA therapies. The organoid model addresses limitations in traditional in vitro systems, providing a robust platform for efficacy testing of therapeutic and cosmetic interventions targeting androgenic alopecia.
2. Enhanced biodistribution and efficacy of nicomenthyl encapsulated in emulsions stabilized by methacrylated hyaluronic acid for the prevention and treatment of skin photoaging.
Methacrylated hyaluronic acid–stabilized emulsions (265 nm) delivering 5 wt% nicomenthyl enhanced dermal penetration, increased COL I/III and elastin expression, accelerated scratch closure, and normalized UVB-induced IL-6/IL-8 in vitro and ex vivo. Biodistribution studies showed delivery to the stratum basale within 24 h, with epidermal SPTLC2 and dermal ELN upregulation.
Impact: Provides a translatable delivery platform that overcomes stratum corneum retention of nicomenthyl, coupling improved biodistribution with functional anti-inflammatory and extracellular matrix restoration relevant to photoaging.
Clinical Implications: Supports development of UV-protective and anti-aging cosmetic formulations by enhancing dermal delivery and activity of a vitamin B3 prodrug; clinical safety and efficacy studies are needed before patient-facing claims.
Key Findings
- HA-MA–stabilized emulsions (265 nm) containing 5 wt% nicomenthyl increased COL I/III by 3.22- and 2.84-fold and elastin by 1.98-fold in HDFs versus baseline.
- EM-NM closed >90% of HaCaT/HDF scratch area at 24 h, outperforming nicomenthyl alone.
- EM-NM normalized UVB-induced IL-6 in irradiated cells and reduced IL-6/IL-8 while restoring COL I/III in photoaged skin models.
- Biodistribution studies showed delivery to the stratum basale within 24 h; SPTLC2 increased 1.87-fold (epidermis) and ELN 1.69-fold (dermis).
Methodological Strengths
- Direct comparison with nicomenthyl alone across in vitro and ex vivo models
- Quantitative biomarker panel (COL I/III, ELN, IL-6/IL-8) with biodistribution assessment
Limitations
- No in vivo animal or human clinical data to confirm long-term efficacy and safety.
- Regulatory and safety considerations for methacrylated HA in topical use were not addressed.
Future Directions: Evaluate long-term safety, pharmacokinetics, and efficacy in animal models and early-phase clinical studies; assess scalability, stability, and compatibility in commercial formulations.
Nicomenthyl (NM), prodrug of niacinamide (vitamin B3), is widely used in skin applications for their biological benefits, but remain mainly in the stratum corneum (SC). Bioactive methacrylate-functionalized hyaluronic acid (HA-MA) (44.5 KDa; degree of substitution: 80-100%), used to stabilize Oil-in-Water emulsions (EM) as new application for polysaccharide, represent an effective strategy to trespass SC. Here, 265 nm stable EMs containing 5 wt% NM (EM-NM) resulted in 3.22, 2.84 and 1.98 fold-increase of COL I/III and Elastin expression, respectively, compared to basal levels of HDF cells. After 24 h, >90% of HaCat/HDF scratched area was covered with EM-NM, significantly higher than NM alone. UVB protection and anti-inflammatory activity of EM-NM were confirmed by recovering IL-6 basal level for UV-irradiated HaCat/HDF cell. While EM-NM reached stratum basale after 24 h-biodistribution studies, it reduced UVB-induced IL-6/IL-8 expression and restored COL I/III expression in photoaged skin models to healthy skin phenotype. While SPTLC2 expression was increased by 1.87-fold in the epidermis, ELN expression was increased by 1.69-fold in the dermis. Altogether, EM-NM proved to enhance NM biological activity and promote skin barrier function of the epidermis and increase elastin production in the dermis, highlighting its potential as a UV-protective and anti-aging cosmetic ingredient.
3. Experimental Investigation of the Crystallization and Thermal Behavior of Animal Fat Mixtures Using a Multi-Technique Approach.
Using DSC, in situ turbidity, and synchrotron SAXS/WAXS under static and sheared conditions, the study links TAG composition of beef and chicken fats to crystallization behavior and polymorphism. All three main polymorphs and transitions were detected, and shear promoted formation of more stable polymorphs.
Impact: Delivers mechanistic structure–processing–property relationships for animal fats relevant to cosmetic and dermal product texture, stability, and sensory design, supported by state-of-the-art synchrotron methods.
Clinical Implications: Not directly clinical; informs cosmetic formulation by guiding TAG composition selection and processing (e.g., shear) to achieve desired polymorphs, improving product stability and sensory performance.
Key Findings
- Crystallization behavior of chicken and beef fats closely correlates with their TAG composition.
- Synchrotron SAXS/WAXS identified all three main polymorphs and their possible transitions in both fat types.
- Shear conditions promoted the crystallization of more stable polymorphs compared with static conditions.
- Solid fat content and thermal behavior were quantified via SFC determination and DSC.
Methodological Strengths
- Three complementary structural/thermal techniques including synchrotron SAXS/WAXS
- Evaluation under both static and shear conditions to mimic processing
Limitations
- Limited to two animal fat sources; generalizability to other fats and complex formulations is uncertain.
- No direct linkage to end-product performance or long-term storage stability testing.
Future Directions: Extend to mixed and structured lipids used in cosmetics, model kinetic pathways under industrial shear/temperature profiles, and correlate polymorphism with macroscopic texture and stability metrics.
Fats are essential ingredients widely used in the food industry, as well as in cosmetic and pharmaceutical formulations. Solid fats are complex multicomponent systems primarily composed of triacylglycerols (TAGs), which determine the types and properties of the crystalline structures formed. TAGs crystallize in different polymorphs and stacking configurations, with distinct thermal and mechanical properties that influence the macroscopic structure and sensory profile of fat-based products. In this study, a comprehensive multi-technique analysis of animal-derived fats, specifically chicken and beef fats, was conducted. Chemical characterization was performed and solid fat content (SFC) was determined. Thermal behaviour was investigated using differential scanning calorimetry (DSC), whereas crystallization experiments were conducted using in situ turbidity measurements and synchrotron small-angle and wide-angle x-ray scattering (SAXS/WAXS) for structural characterization. Three different synchrotron experimental setups were used for crystallization experiments, including static and sheared conditions. The results demonstrate that the crystallization behaviour of beef and chicken fat samples closely correlate with their TAGs composition. Synchrotron x-ray scattering provided structural insights, highlighting how the polymorphic behaviour is influenced by fat origin and crystallization conditions. For both animal fat types, all three main polymorphs and possible transitions were detected. Moreover, the presence of shear promoted crystallization of stable polymorphs.